Inspiris Resilia Durability Registry

Active, not recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

April 26, 2019

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

AVR with or without CABG

Surgical aortic valve implantation with INSPIRIS RESILIA Aortic Valve™

Trial Locations (21)

1080

Heart Center Hietzing, Vienna

1090

Medical University Vienna, Vienna

3100

University Clinics St. Pölten, Sankt Pölten

13005

Hopital de la Timone, Marseille

20138

Centro Cardiologico Monzino, Milan

30120

University Hospital Virgen de la Arrixaca, Murcia

35033

Centre Hospitalier Universitaire (CHU) de Rennes, Rennes

44100

L'institut du thorax - CHU (Centre Hospitalier Universitaire de Nantes), Nantes

50139

University Hospital Careggi, Florence

79106

UNIVERSITÄTSKLINIKUM FREIBURG, Universitäts-Herzzentrum Herz- und Gefäßchirurgie, Freiburg im Breisgau

84131

AOU San Giovanni di Dio e Ruggi d'Aragona, Salerno

Unknown

KU Leuven, Leuven

CHRU - Hospital Trousseau, Tours

Heart Center Leipzig, Leipzig

European Hospital Rome, Roma

H1T 1C8

Institut de Cardiologie de Montréal, Université de Montréal, Montreal

G1v 0A6

Laval University, Québec

3015 CE

Erasmus Medisch Centrum, Rotterdam

EH1 3EG

NHS Lothian, Edinburgh

LE3 9QP

Glenfield Hospital, Glenfield

SE5 9RS

King's College Hospital NHS Foundation Trust, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Edwards Lifesciences

INDUSTRY

lead

Institut für Pharmakologie und Präventive Medizin

NETWORK